Porcine reproductive and respiratory syndrome (PRRS) continues to be one of the most important swine diseases worldwide. Interferon-c (IFNc)-mediated type I cell-mediated immune response plays an important role in protection from, and clearance of, PRRS virus (PRRSV). Several lymphocyte subsets including T-helper, CTLs, Th/memory cells, and cd T lymphocytes were previously reported to produce IFNc during PRRSV infection. However, the proportion and phenotypic characterization of these IFNc-secreting lymphocytes have not been explored. In this study, IFNc producted by different lymphocyte subsets was assessed by multi-color flow cytometry after vaccination with PRRSV modified live vaccine (PRRSV-MLV) and challenge with homogeneous or heterogeneous PRRSV. The results showed that T-helper cells were the major IFNc-secreting cell population after PRRSV-MLV vaccination and PRRSV challenge. Additionally, the proportion of IFNc producing Th/memory cells and cd T cells increased after PRRSV challenge. This difference was accounted for an enhanced ability to produce IFNc in Th/memory cells and an enlarged quantity of cd T cells. The results presented here could contribute to our understanding of the roles of IFNc in protective immunity against PRRSV infection and may be useful for assessment of cell-mediated immunity in vaccine tests.
Introduction
Porcine reproductive and respiratory syndrome (PRRS) is characterized by reproductive failure in sows and gilts, along with increased preweaning mortality in piglets. The causative agent, PRRS virus (PRRSV), belongs to the family Arteriviridae, order Nidovirales (Guo et al. 2013) . Immunologically, PRRSV infection is characterized by delayed humoral and cell-mediated responses (Chand 2012 PRRSV non-neutralizing antibody can be detected at 7 days post-infection, and this IgG Ab is primarily directed towards nucleocapsid (N) protein and provides no protection against PRRSV infection (Sun et al. 2008a, b) . PRRSV-specific neutralizing antibody can be detected 3 weeks after infection. In the presence of neutralizing antibody, low levels of PRRSV replication still occur in lung and lymphoid tissues, indicating that other immune mechanisms could be involved in the complete elimination of the virus (Zhang et al. 2012) . Cell-mediated immunity (CMI) can be detected 4 weeks post-infection. CMI plays an important role in the resolution of many viral infections through the function of cytotoxic T lymphocytes (CTLs) and T helper (Th) lymphocytes (Sun et al. 2008a, b) . IFNc is a pleiotropic cytokine produced by activated T cells and natural killer cells and plays a pivotal role in immune response (Lunney et al. 2010) . IFNc is the principal activator of macrophage function, modulates the growth and differentiation of cytotoxic T cells, activates NK cells, and regulates B cell Ig isotype switching to shift the balance towards a Th1-type response. As the major mediator of CMI response, IFNc is associated with protection against PRRSV infection. Porcine T cells can be divided into a number of subpopulations, including a prominent fraction of T cells expressing T cell receptors (TCR) with cd chains (Gerner 2009 ? CD8 ? T cells is a peculiarity of the porcine immune system. Th/memory cells are a major IFNc-secreting cell population and possess memory, T-helper, and cytolytic properties (Sinkora and Butler 2009) . Swine also possess a large percentage of cd T lymphocytes in the peripheral circulation, which are capable of responding to various pathogens in both innate and specific immune responses (Murtaugh and Genzow 2011) . Similar to ab lymphocytes, cd lymphocytes secrete cytokines, including IFNc, proliferate, and exert antigendriven cytolytic activity (Kimman et al. 2009 ).
Several porcine lymphocyte subsets including T-helper, CTLs, Th/memory, and cd T lymphocytes contribute to IFNc production during PRRSV infection (Xiao et al. 2004) . T cell secretion of IFNc in response to PRRSV appears to be restricted to CD4
? CD8 ? Th/memory cells and CD4
? T-helper cells (Rodriguez-Carreno et al. 2002) . However, the proportions and phenotypes of these IFNcsecreting lymphocytes have not been explored. In this study, pigs were vaccinated with PRRSV-modified live vaccine (PRRSV-MLV) and then challenged with homologous VR2332 or heterologous JXA1 PRRS viruses to analyze the phenotypic characteristics and proportions of lymphocyte subsets contributing to IFNc production.
Materials and Methods

Cells and Viruses
Marc-145 cells were maintained in Modified Eagle's medium supplemented with 7% fetal bovine serum (FBS) containing 100 U penicillin/mL and 100 lg streptomycin/mL at 37°C with 5% CO 2 . Virus stocks were prepared and titered in Marc-145 cells and stored in aliquots at -80°C until use. For virus infection and titration, minimum Eagle's medium (MEM) supplemented with 2% FBS was used. PRRSVmodified live virus vaccine (MLV) was bought from Boehringer Ingelheim Vetmedica Inc. PRRSV VR-2332 and JXA1 strains were kept in our laboratory.
Pigs, Vaccination, and Viral Challenge Study
Twenty-five 3-week old conventional large White-Duroc crossbred weaned specific-pathogen free piglets were randomly divided into five groups (n = 5). These piglets were confirmed PRRSV negative by ELISA and RT-PCR. Pigs in the first two groups were immunized intramuscularly on day 0 post-vaccination (DPV) with vaccine (PRRSV-MLV, 1 9 10 6 TCID 50 /pig). After 4 weeks, pigs in groups 1 and 3 were challenged with homologous PRRSV VR-2332 (1 9 10 6 TCID 50 /pig) and pigs in groups 2 and 4 were challenged with heterologous PRRSV JXA1 (25th passage) (1 9 10 6 TCID 50 /pig) intramuscularly. Pigs in group 5 served as negative controls and received MEM without virus challenge. Pigs were humanely euthanized at day 14 post-challenge (DPC). All animal experiments were approved by the Institutional Animal Care and Use Committee at National Research Center for Veterinary Medicine and conventional animal welfare regulations and standards were adhered to.
Collection of Blood Samples for Analysis
Blood was collected on 28 DPV and 14 DPC. Fresh blood samples were directly subjected to flow cytometry analysis. Peripheral blood mononuclear cells (PBMCs) were isolated from heparinized blood samples by Ficoll-Hypaque gradient centrifugation using Histopaque Ò -1077 (SigmaAldrich, St. Louis, MO). PBMCs were used for ELISpot assay.
ELISpot Assay and Flow Cytometry Analysis
In brief, half a million PBMCs were plated in enriched RPMI (Thermo Fisher Scientific, MA) in a 96-well multiscreen plate (Millipore, Billerica, MA) which had been precoated overnight with capture IFNc mAB (BD pharMingen, San Diego, CA). PBMCs were re-stimulated with 1 9 10 5 TCID 50 inactivated PRRSV VR2332 or JXA1 for 24 h at 37°C. IFNc-secreting cells were detected using a biotinylated anti-pig IFNc detection antibody (clone P2C11) and visualized using an immunospot image analyzer (Cellular Technology, Cleveland, OH). Data are presented as mean numbers of antigen-specific IFNc-secreting cells per 10 6 PBMCs from duplicate wells of each sample.
Four-color or three-color flow cytometric assays were developed to identify different lymphocyte subsets. In the four-color cell staining protocol, FITC-labeled mouse antipig CD3e (clone BB23-8E6-8C8), PerCP-Cy TM 5.5-labeled mouse anti-pig IFNc (clone P2G10), PE-labeled mouse anti-pig CD4a (clone 74-12-4), and APC-labeled mouse anti-pig CD8a (clone MIL12) antibodies were used. In brief, 1 lL Brefeldin A (Biolegend, San Diego, CA), which blocks protein secretion and leads to IFNc accumulation in the Golgi complex, was added to cells. Cells were permeabilized with permeabilization/fixation buffer (Biolegend, San Diego, CA) the stained with PerCP-Cy TM 5.5-labeled mouse anti-pig IFNc. After rinsing in phosphate buffered saline three times, cells were stained with other three antibodies. Different lymphocyte populations identified based on cell surface marker phenotype were T-helper cells (CD3
The three-color cell staining protocol was used to identify the cd T cell population. PerCP-Cy TM 5.5 mouse anti-pig IFN-c (clone P2G10), FITC-labeled mouse anti-pig CD8a (clone 76-2-11), and mouse anti-pig cd T cell (TcR1N4, purchase from VMRD. Pullman, WA) antibodies were used. The staining protocol used was for four-color flow cytometric assays as described. Unless otherwise noted, all commercial antibodies listed were purchased from BD Biosciences. Cells were acquired using a FACS Calibur (BD Biosciences) flow cytometer. Frequencies of individual lymphocytes were analyzed by one million events using FlowJo software (Tree Star, Inc., OR, USA).
Analysis of Viremia Using Real-Time PCR
Total RNA was extracted from serum collected on 7 DPC and 14 DPC. One-step SyBR Green real-time PCR (BioRad, Hercules, CA) was performed to evaluate the PRRSV ORF7 expression level. For quantification, VR2332 PRRVS RNA of a known TCID 50 was serially diluted and used to generate a standard curve. The virus quantities in unknown samples were determined by linear extrapolation of the Ct value plotted against the standard curve (Li et al. 2013) .
Statistical Analysis
All data are expressed as the mean value from five pigs ± SEM. The percentage difference in IFNc-secreting cells between two PRRSV challenge strains was determined by student t test (Prism5.0, GraphPad Software, SanDiego, CA). Differences were considered statistically significant when P \ 0.05.
Results
Flow Cytometry Setup to Differentiate Subsets of Lymphocytes
Brefeldin A blocks protein secretion and leads to the accumulation of IFNc in the Golgi complex (Li et al. 2013) . Whole blood samples, from naïve or vaccinated pigs, were stimulated with inactivated PRRSV to measure IFNc production in the presence of Brefeldin A. Blood samples without any stimulation served as a control. The four-color flow cytometric assay was developed for the phenotypic characterization of porcine IFNc-producing lymphocytes. No fluorescence signal was detected in unstimulated cells (Supplementary Figure S1A) . After PRRSV stimulation, naïve porcine blood had a low frequency (0.09% ± 0.03%) of IFNc-producing cells in CD3-gated lymphocytes (Supplementary Figure S1B) . The frequency of IFNc-producing cells in blood from PRRSVvaccinated pigs (0.42% ± 0.12%) was higher than that observed in naïve porcine blood (Supplementary Figure S1C, Figure S1C right bottom) . cd T cells are another important porcine IFNc producing T lymphocyte resource. To determine the proportion of cd T cells contributing to IFNc production after PRRSV stimulation, CD8
? and cd ? cell populations were gated and defined as cd T cells in IFNc-producing lymphocytes (Supplementary Figure S1D) .
Frequency of IFNc-Secreting Cells After PRRSV-MLV Vaccination
Whole blood samples were collected at 28 DPV and PBMCs were isolated to perform an ELIspot assay to quantify IFNc-secreting cells. Only PRRSV-MLVvaccinated pigs developed PRRSV-specific IFNc-secreting cells at 28 DPV (Fig. 1) . As expected, the frequency of PRRSV-specific IFNc-secreting cells in naïve pigs was negligible. There was no significant difference in the frequency of IFNc-secreting cells following PBMC stimulation with PRRSV VR2332 or JXA1 strains.
Contribution of Different Lymphocyte Subsets to IFNc Production After PRRSV-MLV Vaccination
Different PBMC T cell subsets were analyzed at 28 DPV. The percentages of all T cell subsets were increased in vaccinated pigs compared with unvaccinated pigs (Table 1) . Since T-helper cells, cytotoxic T cells, Th/memory cells, NK cells, and cd T cells were reported to be responsible for IFNc generation, we next explored the contribution of the different cell subsets to IFNc production after PRRSV-MLV vaccination. Of the different lymphocyte subsets, T-helper cells accounted for over 30% of total IFNc-secreting cells (Fig. 2) . cd T cells are T cell subsets unique to porcine blood and are important resources for IFNc production, especially in young pigs. cd T cells accounted for approximately 13% of IFNc production following PRRSV vaccination (Fig. 2) . CTLs and Th/memory cells accounted for 6% and 7% of total IFNcsecreting cells, respectively. NK cells accounted for 3% of total IFNc-secreting cells.
Frequency of IFNc-Secreting Cells After Homologous or Heterologous PRRSV Challenge
All pigs were challenged with homologous VR2332 (shares 98.9% genome similarity with PRRSV-MLV) or heterologous JXA1 (shares 89.4% genome similarity with PRRSV-MLV) at 28 DPV. Different PBMC T cell subsets were also analyzed at 14 DPC. Except for T-helper cells (in the VR2332-challenge scenario) and cd T cells, the percentages of all T cell subsets were decreased in unvaccinated pigs irrespective of whether challenged with VR2332 or JXA1 (Table 2 ). In contrast, the percentages of all T cell subsets were increased in vaccinated pigs. PBMCs from PRRSV-challenged pigs were stimulated with VR2332 or JXA1 PRRSVs before performing ELIspot assay. At 14 DPC, the IFNc-secreting cells population increased significantly in PRRSV-MLV vaccinated pigs (MLV ? VR2332 and MLV ? JXA1 groups) compared with that in unvaccinated pigs (Naïve ?VR2332 and Naïve ?JXA1 groups) (Fig. 3 ). There was a higher frequency of IFNc-secreting cells in VR2332-challenged pigs following PBMCs re-stimulation with homologous VR2332 virus than with heterologous JXA1 virus (within MLV ? VR2332 group). Compared to pigs challenged with VR2332, JXA1-challenged pigs developed more IFNc-secreting cells Table 1 Frequency of T cell subsets in pigs after vaccination. Peripheral blood mononuclear cells (PBMCs) were isolated from blood collected from pigs at 28 DPV.
Cells Unvaccinated Vaccinated
Total T cell 55.3 ± 9.8 61.9 ± 11.4
T-helper cell 10.1 ± 4.3 15.6 ± 3.7 CTL 29.6 ± 7.1 32.1 ± 8.9 NK cell 11.7 ± 5.6 12.2 ± 3.4 cd T cell 8.5 ± 4.9 13.7 ± 4.1
Th/memory cell 8.8 ± 2.4 9.5 ± 3.8
T cell subsets were counted by flow cytometry according to their phenotypes. Each number is expressed as the average percent of total PBMCs from 10 vaccinated pigs ± SEM and 15 unvaccinated pigs ± SEM. (MLV ? VR2332 group vs. MLV ? JXA1 group). However, there was no significant difference in IFNc production following PBMC re-stimulation with VR2332 or JXA1 in this pig group (MLV ? JXA1 group).
Contribution of Different Lymphocyte Subsets to IFNc Production After PRRSV Challenge
To determine how the different cell populations contributing to IFNc production when vaccinated pigs re-encountered PRRSVs, the percentages of IFNc-secreting cells of different populations were analyzed. T-helper cells still accounted for the largest cell proportion after viral challenge, followed by cd T cells and Th/memory cells (Fig. 4) . The percentages of IFNc-secreting cells within each cell population were compared following VR2332 or JXA1 challenge. The percentage of Th/memory cells for total IFNc-secreting cells was significantly higher in VR2332-challenged pigs than in JXA1-challenged pigs.
There was no significant difference as for the percentage of other cell populations for total IFNc-secreting cells after VR2332 or JXA1 virus challenges.
Viremia Profiles at 7 DPC and 14 DPC
To explore the correlation between IFNc production and virus load, serum sample virus titer was measured using real-time PCR. MLV-vaccinated pigs had decreased serum sample virus titers 7 DPC (Fig. 5) . On DPC 14, the virus titer in vaccinated pigs was significantly lower than that of unvaccinated pigs, which illustrated the efficacy of vaccination. Compared to the pigs in the heterologous challenge group (MLV ? JXA1), the viremia of pigs in the homologous challenge group (MLV ? VR2332) was undetectable. No clinical symptoms were exhibited by any vaccinated pigs. By contrast, unvaccinated pigs challenged with VR2332 had a transient fever (2-5 DPC) and no other clinical symptoms were observed. Unvaccinated pigs challenged with JXA1 had lasting fever from 2 to 10 DPC and showed transient clinical symptoms including dyspnea, coughing, and shivering. All pigs that survived to the end of study were terminated at 14 DPC.
Discussion
IFNc plays pivotal roles in host cell-mediated immunity including in facilitating complete viral clearance and providing protection when reencountering the same pathogen in PRRSV infection (Toyoda et al. 2012) . In human and rodents, IFNc is produced by T lymphocytes and NK cells (Keane et al. 2012) . Porcine peripheral T lymphocytes have two unique subsets: Th/memory and cd T cells. To date, Th, CTLS, Th/memory, and cd T lymphocytes have been reported to produce IFNc after virus infection. Previous studies indicated that PRRSV-specific cell-mediated immunity, assessed by IFNc-secreting cells, contributes to complete virus clearance (Costers et al. 2009 ). However, the nature of porcine IFNc-producing lymphocytes following Total T cell 52.8 ± 11.4 46.2 ± 12.5 42.8 ± 11.1 55.0 ± 13.9 57.2 ± 11.8 T-helper cell 11.3 ± 3.7 13.6 ± 4.1 10.4 ± 3.7 13.1 ± 2.7 14.3 ± 3.5 CTL 25.0 ± 6.8 23.4 ± 9.6 21.8 ± 13.0 27.4 ± 6.3 25.2 ± 5.9
NK cell 10.4 ± 4.5 8.3 ± 4.7 6.9 ± 2.6 11.2 ± 3.3 15.6 ± 4.4 cd T cell 9.0 ± 5.1 11.9 ± 3.3 11.4 ± 3.9 14.4 ± 2.6 13.9 ± 4.2
Th/memory cell 8.4 ± 3.0 6.9 ± 3.5 5.5 ± 2.1 9.5 ± 3.4 8.7 ± 3.7
T cell subsets were counted by flow cytometry according to their phenotypes. Each number is expressed as the average percent of total PBMCs from 5 pigs ± SEM in each group. PRRSV infection has not yet been elucidated. In this study, we first explored the contribution of different lymphocyte subsets to IFNc production after PRRSV vaccination and compared the phenotypes of IFNc-secreting cells following homologous and heterologous virus challenge. The multiple-color flow cytometric assay was developed to delineate the percentage of porcine peripheral blood lymphocytes that produce IFNc upon stimulation with PRRSV. ELIspot and flow cytometric assay results showed that unvaccinated pigs did not develop PRRSV-specific IFNc-secreting cells. In vaccinated pigs, the major proportion of IFNc-producing cells after vaccination were Th cells, followed by cd T cells, Th/memory cells, and CTLs (Fig. 2) . After viral challenge, increased IFNc-producing cell proportions were observed in Th/memory and cd T cell populations, although Th cells remained the highest proportion of IFNc-secreting cells (Fig. 4) . These results are consistent with those of a previous report which showed that Th cells constitute a higher proportion of IFNc-secreting cells when vaccinated pigs are challenged with VR2332 and a local strain of KS-06 (Li et al. 2014) . Additionally, the similar frequencies of different T lymphocytes in response to VR2332 and JXA1 PRRSV challenge suggest that different PRRSV challenge does not affect T cell populations. CD4
?
CD8
? double positive T cells, exhibiting features of memory cells, play a particularly important role in IFNc production when pigs reencounter PRRSV. The capacity of CD4 ?
? T cells to produce high levels of IFNc has been reported previously (De Bruin et al. 2000) . The increased proportion of Th/memory cells contributing to IFNc production was assumed to result from increased ability to secret IFNc because the percentage of Th/memory cells in lymphocytes before and after virus challenge remained stable. Compared to JXA1 heterologous challenge pigs, Th/memory cells generated in VR2332-challenged pigs were responsible for a higher proportion of IFNc production (Fig. 4) . PRRSV structural Gp5 and M proteins were reported to induce IFNc production after PPRSV infection (Jiang et al. 2006) . The amino acid of these two structural proteins in MLV and VR2332 share more than 99.2% similarity, while JXA1 shares only 89.4% similarity with MLV. This could explain the disparity of IFNc production in Th/memory cells when vaccinated pigs were challenged with different PRRSV strains.
The proportion of cd T cells that contributed to IFNc production increased after virus challenges. cd T lymphocytes are not linked to major histocompatibility complex (MHC) or non-MHC genes, and do not have memory characteristics (Riganti et al. 2012) . Therefore, the increased contribution to IFNc production by cd T cells may simply be due to increased numbers of these cells in blood. Also, a similar percentage of cd T cells contributed to IFNc production after VR2332 or JXA1 challenge, illustrating that there was no phenotypic memory response (Fig. 4) .
After JXA1 PRRSV re-stimulation, pigs in the MLV ? JXA1 group had higher proportions of IFNc-secreting cells in their PBMCs (Fig. 3) . However, the viremia level in the pigs of this group was significantly higher than in the pigs in the MLV ? VR2332 group. In Xiao's study, they reported that the level of IFNc expression after PRRSV infection was variable and did not correlate with virus load (Xiao et al. 2004) . Moreover, other immune factors, such as IFNa, have recently been shown to alter adaptive immune responses to PRRSV (Zhang et al. 2012) .
In summary, we used the ELIspot assay and flow cytometry to analyze the percentages of different lymphocyte subsets contributing to IFNc production after PRRSV vaccination and challenge. We then delineated the change profiles of different T lymphocyte subset following homologous and heterologous PRRSV challenges. Our results will extend our understanding of the roles of IFNc in protective immunity against PRRSV infection. Moreover, our results will provide useful information to elicit superior IFNc-mediated CMI response and better crossprotective immunity in future PRRSV vaccine design.
